Investors Research Corp Has $903,000 Holdings in CVS Health Co. (NYSE:CVS)

Investors Research Corp lessened its holdings in shares of CVS Health Co. (NYSE:CVS) by 7.3% during the fourth quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 20,112 shares of the pharmacy operator’s stock after selling 1,595 shares during the quarter. Investors Research Corp’s holdings in CVS Health were worth $903,000 at the end of the most recent reporting period.

A number of other institutional investors have also recently bought and sold shares of the business. MidAtlantic Capital Management Inc. acquired a new position in shares of CVS Health in the third quarter valued at approximately $25,000. Legacy Investment Solutions LLC acquired a new position in shares of CVS Health in the third quarter valued at approximately $31,000. Ridgewood Investments LLC grew its position in shares of CVS Health by 255.7% in the fourth quarter. Ridgewood Investments LLC now owns 626 shares of the pharmacy operator’s stock valued at $28,000 after purchasing an additional 450 shares during the last quarter. Stonebridge Financial Group LLC acquired a new position in shares of CVS Health in the fourth quarter valued at approximately $28,000. Finally, RPg Family Wealth Advisory LLC bought a new stake in shares of CVS Health in the third quarter valued at approximately $40,000. Institutional investors and hedge funds own 80.66% of the company’s stock.

Insider Transactions at CVS Health

In other CVS Health news, Director Michael F. Mahoney purchased 30,000 shares of the company’s stock in a transaction that occurred on Tuesday, February 18th. The shares were acquired at an average price of $66.70 per share, with a total value of $2,001,000.00. Following the transaction, the director now owns 39,356 shares in the company, valued at $2,625,045.20. The trade was a 320.65 % increase in their ownership of the stock. The acquisition was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, SVP James David Clark sold 7,513 shares of the firm’s stock in a transaction dated Wednesday, March 5th. The shares were sold at an average price of $66.35, for a total transaction of $498,487.55. Following the completion of the transaction, the senior vice president now directly owns 8,394 shares in the company, valued at approximately $556,941.90. The trade was a 47.23 % decrease in their position. The disclosure for this sale can be found here. Insiders own 0.24% of the company’s stock.

Analyst Upgrades and Downgrades

Several equities research analysts recently issued reports on CVS shares. Leerink Partners upgraded CVS Health from a “market perform” rating to an “outperform” rating and boosted their price target for the company from $55.00 to $75.00 in a research note on Thursday, February 13th. Barclays upped their target price on CVS Health from $71.00 to $73.00 and gave the stock an “overweight” rating in a research note on Thursday, February 13th. TD Cowen upped their target price on CVS Health from $73.00 to $80.00 and gave the stock a “buy” rating in a research note on Monday, November 25th. Piper Sandler cut their target price on CVS Health from $72.00 to $64.00 and set an “overweight” rating for the company in a research note on Monday, November 25th. Finally, Wolfe Research upped their target price on CVS Health from 67.00 to 70.00 and gave the stock an “overweight” rating in a research note on Tuesday, February 11th. Four research analysts have rated the stock with a hold rating, seventeen have issued a buy rating and one has given a strong buy rating to the company’s stock. According to MarketBeat.com, the stock has a consensus rating of “Moderate Buy” and an average price target of $69.83.

CVS Health Stock Performance

Shares of CVS Health stock opened at $66.34 on Monday. The company has a current ratio of 0.81, a quick ratio of 0.60 and a debt-to-equity ratio of 0.80. The business has a 50-day moving average price of $56.42 and a two-hundred day moving average price of $56.73. CVS Health Co. has a 1-year low of $43.56 and a 1-year high of $80.75. The company has a market cap of $83.64 billion, a P/E ratio of 18.12, a PEG ratio of 0.98 and a beta of 0.54.

CVS Health (NYSE:CVS) last released its quarterly earnings data on Wednesday, February 12th. The pharmacy operator reported $1.19 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.89 by $0.30. CVS Health had a net margin of 1.24% and a return on equity of 9.11%. As a group, analysts anticipate that CVS Health Co. will post 5.89 EPS for the current year.

CVS Health Dividend Announcement

The business also recently disclosed a quarterly dividend, which was paid on Monday, February 3rd. Stockholders of record on Thursday, January 23rd were given a dividend of $0.665 per share. The ex-dividend date was Thursday, January 23rd. This represents a $2.66 dividend on an annualized basis and a dividend yield of 4.01%. CVS Health’s dividend payout ratio (DPR) is presently 72.68%.

About CVS Health

CVS Health Corporation provides health solutions in the United States. It operates through Health Care Benefits, Health Services, and Pharmacy & Consumer Wellness segments. The Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services.